McCusker C, Warrington R. Primary immunodeficiency. Allergy Asthma Clin Immunol. 2011;7(1):1–8.
Modell V, et al. Global overview of primary immunodeficiencies: a report from Jeffrey modell centers worldwide focused on diagnosis, treatment, and discovery. Immunol Res. 2014;60(1):132–44.
Article PubMed CAS Google Scholar
Al-Herz W, et al. Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population. Front Immunol. 2019;9:3146.
Article PubMed PubMed Central Google Scholar
Tangye SG, et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473–507.
Article PubMed PubMed Central Google Scholar
Rezaei N, et al. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol. 2011;127(6):1329-1341.e2.
Bazregari S, et al. Evaluation of infectious and non-infectious complications in patients with primary immunodeficiency. Cent-Eur J Immunol. 2017;42(4):336.
Article PubMed PubMed Central CAS Google Scholar
Mortaz E, et al. Cancers related to immunodeficiencies: update and perspectives. Front Immunol. 2016;7:365.
Article PubMed PubMed Central Google Scholar
Hauck F, et al. Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders. J Allergy Clin Immunol. 2018;141(1):59-68.e4.
Shapiro RS. Malignancies in the setting of primary immunodeficiency: implications for hematologists/oncologists. Am J Hematol. 2011;86(1):48–55.
Abolhassani H, et al. Hallmarks of cancers: primary antibody deficiency versus other inborn errors of immunity. Front Immunol. 2021;12:720025.
Article PubMed PubMed Central CAS Google Scholar
Tiri A, et al. Inborn errors of immunity and cancer. Biology. 2021;10(4):313.
Article PubMed PubMed Central CAS Google Scholar
Haas OA. Primary immunodeficiency and cancer predisposition revisited: embedding two closely related concepts into an integrative conceptual framework. Front Immunol. 2019;9:3136.
Article PubMed PubMed Central Google Scholar
Wang Y, Abolhassani H. Updates of cancer hallmarks in patients with inborn errors of immunity. Curr Opin Allergy Clin Immunol. 2022;22(6):352–63.
Article PubMed PubMed Central CAS Google Scholar
Mayor PC, et al. Cancer in primary immunodeficiency diseases: cancer incidence in the United States immune deficiency network registry. J Allergy Clin Immunol. 2018;141(3):1028–35.
Bogdanova N, et al. Nijmegen breakage syndrome mutations and risk of breast cancer. Int J Cancer. 2008;122(4):802–6.
Article PubMed CAS Google Scholar
Kebudi R, Kiykim A, Sahin MK. Primary immunodeficiency and cancer in children; a review of the literature. Curr Pediatr Rev. 2019;15(4):245–50.
Article PubMed PubMed Central Google Scholar
Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
Article PubMed PubMed Central Google Scholar
Kocarnik JM, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8(3):420–44.
Gross T, Shiramizu, B. Lymphoproliferative disorders and malignancies related to immunodeficiencies. Principles and practice of pediatric oncology. Philadelphia, PA: Lippincott Williams & Wilkins, 2006. 748.
Herber M, et al. Primary immunodeficiencies and lymphoma: a systematic review of literature. Leuk Lymphoma. 2020;61(2):274–84.
Article PubMed CAS Google Scholar
Suarez F, et al. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol. 2015;33(2):202–8.
Zheng B, et al. Immunogenetics of gastrointestinal cancers: a systematic review and retrospective survey of inborn errors of immunity in humans. J Gastroenterol Hepatol. 2022;37(6):973–82.
Article PubMed PubMed Central Google Scholar
Salavoura K, et al. Development of cancer in patients with primary immunodeficiencies. Anticancer Res. 2008;28(2B):1263–9.
Jiang W, et al. Exhausted CD8+ T cells in the tumor immune microenvironment: new pathways to therapy. Front Immunol. 2021;11:622509.
Article PubMed PubMed Central Google Scholar
Magen E, et al. Helicobacter pylori infection in patients with selective immunoglobulin a deficiency. Clin Exp Immunol. 2016;184(3):332–7.
Article PubMed PubMed Central CAS Google Scholar
Quiding-Järbrink M, et al. Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients. Clin Immunol. 2009;131(3):463–71.
Frigerio S, et al. The role of the immune system in IBD-associated colorectal cancer: from pro to anti-tumorigenic mechanisms. Int J Mol Sci. 2021;22(23):12739.
Article PubMed PubMed Central CAS Google Scholar
Kralickova P, et al. CVID-associated tumors: Czech nationwide study focused on epidemiology, immunology, and genetic background in a cohort of patients with CVID. Front Immunol. 2018;9:3135.
Article PubMed CAS Google Scholar
Khanmohammadi S, et al. Lymphoma in the setting of autoimmune diseases: a review of association and mechanisms. Crit Rev Oncol Hematol. 2020;150:102945.
Tak Manesh A, et al. Epidemiology and pathophysiology of malignancy in common variable immunodeficiency? Allergol Immunopathol (Madr). 2017;45(6):602–15.
Article PubMed CAS Google Scholar
Kiaee F, et al. Malignancy in common variable immunodeficiency: a systematic review and meta-analysis. Expert Rev Clin Immunol. 2019;15(10):1105–13.
Article PubMed CAS Google Scholar
Weifenbach N, Schneckenburger AA, Lötters S. Global distribution of common variable immunodeficiency (CVID) in the light of the UNDP human development index (HDI): a preliminary perspective of a rare disease. J Immunol Res. 2020;2020(1):8416124.
PubMed PubMed Central Google Scholar
Gumy-Pause F, Wacker P, Sappino AP. ATM gene and lymphoid malignancies. Leukemia. 2004;18(2):238–42.
Article PubMed CAS Google Scholar
Pasic S, et al. T-cell lymphoblastic leukemia/lymphoma in Nijmegen breakage syndrome. Haematologica. 2004;89(8):ECR27.
Chrzanowska KH, et al. Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis. 2012;7:13.
留言 (0)